Trelmar en es it fr

Trelmar Brand names, Trelmar Analogs

Trelmar Brand Names Mixture

  • No information avaliable

Trelmar Chemical_Formula


Trelmar RX_link

No information avaliable

Trelmar fda sheet

Trelmar msds (material safety sheet)

Trelmar Synthesis Reference

No information avaliable

Trelmar Molecular Weight

309.469 g/mol

Trelmar Melting Point

< 25 oC

Trelmar H2O Solubility

Soluble as HCl salt

Trelmar State


Trelmar LogP


Trelmar Dosage Forms

Tablets (oral, 1 mg)

Trelmar Indication

Used for the symptomatic treatment of parkinsonism.

Trelmar Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Trelmar Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Trelmar side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Trelmar Patient Information

Trelmar Organisms Affected

Humans and other mammals